Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pure Extracts Technologies Corp. Regulatory Filings 2021

Mar 5, 2021

45792_rns_2021-03-05_02f42bb4-d727-442f-a391-a52b0637176e.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [106 x 28] intentionally omitted <==

March ___, 2021 5

British Columbia Securities Commission Alberta Securities Commission The Manitoba Securities Commission Ontario Securities Commission Financial and Consumer Services Commission (New Brunswick) Nova Scotia Securities Commission Prince Edward Island Securities Office Financial and Consumer Affairs Authority of Saskatchewan

Dear Sirs/Mesdames:

Re: Pure Extracts Technologies Corp.

5 In connection with the Prospectus Supplement of Pure Extracts Technologies Corp. dated March ___, 2021 (the “ Prospectus ”), we consent to the references to our name under the headings “Legal Matters” and “Interest of Experts” in the Prospectus.

We have read the Prospectus and have no reason to believe that there are any misrepresentations in the information contained therein that is derived from our opinion referred to therein or that is within our knowledge as a result of the services that we performed in connection with such opinion.

Yours truly,

McMillan LLP

McMillan LLP  Royal Centre, 1055 W. Georgia St., Suite 1500, PO Box 11117, Vancouver, BC, Canada V6E 4N7  t 604.689.9111  f 604.685.7084 Lawyers  Patent & Trade-mark Agents  Avocats  Agents de brevets et de marques de commerce Vancouver  Calgary  Toronto  Ottawa  Montréal  Hong Kong  mcmillan.ca

LEGAL_35757056.1